227 filings
Page 5 of 12
8-K
w7u87oky1j
29 Oct 19
NeoGenomics Reports 51% Revenue Growth to $105 Million
7:38am
8-K
xtp418aq
8 Aug 19
Departure of Directors or Certain Officers
7:16am
8-K
37xm npv9m3k1m62z6
2 Aug 19
Regulation FD Disclosure
12:41pm
8-K
gp8qygnhfq30o5r0
30 Jul 19
NeoGenomics Reports 50% Revenue Growth to Record $102 Million
8:04am
8-K
pzoi8oig8sn6l0td
28 Jun 19
NeoGenomics Announces New $250 Million Credit Agreement
4:06pm
8-K
hypg3dhd7
12 Jun 19
Submission of Matters to a Vote of Security Holders
12:00am
8-K
np7dcv 0cnzhg3
22 May 19
NeoGenomics Announces Pricing on Public Offering of Common Stock
8:15am
8-K
i9wtc5
20 May 19
Regulation FD Disclosure
4:37pm
8-K
0g4ubglld6cwg0jed
20 May 19
Financial Statements and Exhibits
4:01pm
8-K
wjgi6ni
2 May 19
INVESTOR PRESENTATION April 2019
12:00am
8-K
ym0q2 lxx
30 Apr 19
NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter
7:43am
8-K
xtmikvetw2rv6 hem6
26 Apr 19
Other Events
5:27pm
8-K
4czhab
5 Mar 19
Changes in Registrant's Certifying Accountant
4:15pm
8-K
0nq5bekl
21 Feb 19
Regulation FD Disclosure
5:08pm
8-K
7j32vvyqmqspd7s4q4f
19 Feb 19
NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter
8:09am
8-K
k0gwcph
14 Dec 18
NeoGenomics Appoints Dr. Lawrence M. Weiss as Chief Scientific Officer
4:30pm
8-K
mffh8va6gp3 ny
12 Dec 18
NeoGenomics Announces Pricing on Secondary Offering of
4:18pm
8-K
ji13kmm797untqn
11 Dec 18
NeoGenomics Announces Secondary Offering of
5:21pm
8-K
5llk3ha
10 Dec 18
Completion of Acquisition or Disposition of Assets
5:14pm
8-K
45crnoqoeoj9l
7 Nov 18
Regulation FD Disclosure
5:22pm